annual cash & cash equivalents:
$2.99B+$1.37B(+84.03%)Summary
- As of today (September 1, 2025), JAZZ annual cash & cash equivalents is $2.99 billion, with the most recent change of +$1.37 billion (+84.03%) on December 31, 2024.
- During the last 3 years, JAZZ annual cash & cash equivalents has risen by +$2.40 billion (+406.02%).
- JAZZ annual cash & cash equivalents is now at all-time high.
Performance
JAZZ Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.67B-$902.07M(-35.07%)Summary
- As of today (September 1, 2025), JAZZ quarterly cash & cash equivalents is $1.67 billion, with the most recent change of -$902.07 million (-35.07%) on June 30, 2025.
- Over the past year, JAZZ quarterly cash & cash equivalents has dropped by -$310.92 million (-15.70%).
- JAZZ quarterly cash & cash equivalents is now -44.20% below its all-time high of $2.99 billion, reached on December 31, 2024.
Performance
JAZZ quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
JAZZ Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +84.0% | -15.7% |
| 3 y3 years | +406.0% | +116.5% |
| 5 y5 years | +177.8% | -1.5% |
JAZZ Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +406.0% | -44.2% | +116.5% |
| 5 y | 5-year | at high | +406.0% | -44.2% | +240.2% |
| alltime | all time | at high | >+9999.0% | -44.2% | >+9999.0% |
JAZZ Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.67B(-35.1%) |
| Mar 2025 | - | $2.57B(-14.1%) |
| Dec 2024 | $2.99B(+84.0%) | $2.99B(+14.3%) |
| Sep 2024 | - | $2.62B(+32.2%) |
| Jun 2024 | - | $1.98B(+8.9%) |
| Mar 2024 | - | $1.82B(+11.8%) |
| Dec 2023 | $1.63B(+84.5%) | $1.63B(+2.6%) |
| Sep 2023 | - | $1.59B(+16.4%) |
| Jun 2023 | - | $1.36B(+16.6%) |
| Mar 2023 | - | $1.17B(+32.5%) |
| Dec 2022 | $881.48M(+49.0%) | $881.48M(-2.0%) |
| Sep 2022 | - | $899.36M(+16.6%) |
| Jun 2022 | - | $771.26M(+57.1%) |
| Mar 2022 | - | $490.83M(-17.0%) |
| Dec 2021 | $591.45M(-72.3%) | $591.45M(-12.0%) |
| Sep 2021 | - | $671.78M(-24.6%) |
| Jun 2021 | - | $891.40M(-63.4%) |
| Mar 2021 | - | $2.43B(+14.1%) |
| Dec 2020 | $2.13B(+98.0%) | $2.13B(+11.3%) |
| Sep 2020 | - | $1.92B(+13.0%) |
| Jun 2020 | - | $1.70B(+72.8%) |
| Mar 2020 | - | $981.60M(-8.9%) |
| Dec 2019 | $1.08B(+30.6%) | $1.08B(+0.7%) |
| Sep 2019 | - | $1.07B(+21.2%) |
| Jun 2019 | - | $882.74M(+6.0%) |
| Mar 2019 | - | $832.47M(+1.0%) |
| Dec 2018 | $824.62M(+33.8%) | $824.62M(-22.7%) |
| Sep 2018 | - | $1.07B(+30.6%) |
| Jun 2018 | - | $816.66M(+15.1%) |
| Mar 2018 | - | $709.78M(+15.1%) |
| Dec 2017 | $616.53M(+44.7%) | $616.53M(+32.7%) |
| Sep 2017 | - | $464.74M(+41.6%) |
| Jun 2017 | - | $328.20M(-19.5%) |
| Mar 2017 | - | $407.49M(-4.3%) |
| Dec 2016 | $425.96M(-56.9%) | $425.96M(-0.0%) |
| Sep 2016 | - | $425.99M(-53.5%) |
| Jun 2016 | - | $916.38M(-6.5%) |
| Mar 2016 | - | $980.54M(-0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $988.78M(+44.6%) | $988.78M(-1.0%) |
| Sep 2015 | - | $998.86M(+8.4%) |
| Jun 2015 | - | $921.64M(+17.8%) |
| Mar 2015 | - | $782.60M(+14.4%) |
| Dec 2014 | $684.04M(+7.5%) | $684.04M(+19.0%) |
| Sep 2014 | - | $575.04M(+114.4%) |
| Jun 2014 | - | $268.25M(+6.7%) |
| Mar 2014 | - | $251.38M(-60.5%) |
| Dec 2013 | $636.50M(+64.4%) | $636.50M(+8.2%) |
| Sep 2013 | - | $588.46M(+16.7%) |
| Jun 2013 | - | $504.31M(+11.9%) |
| Mar 2013 | - | $450.51M(+16.4%) |
| Dec 2012 | $387.20M(+145.2%) | $387.20M(+104.0%) |
| Sep 2012 | - | $189.79M(+22.8%) |
| Jun 2012 | - | $154.54M(-36.7%) |
| Mar 2012 | - | $244.22M(+54.7%) |
| Dec 2011 | $157.90M(+249.4%) | $157.90M(+39.3%) |
| Sep 2011 | - | $113.35M(+10.7%) |
| Jun 2011 | - | $102.40M(+56.4%) |
| Mar 2011 | - | $65.46M(+44.8%) |
| Dec 2010 | $45.19M(+143.2%) | $45.19M(+94.4%) |
| Sep 2010 | - | $23.25M(+121.8%) |
| Jun 2010 | - | $10.48M(-47.4%) |
| Mar 2010 | - | $19.95M(+7.4%) |
| Dec 2009 | $18.58M(-33.2%) | $18.58M(+41.0%) |
| Sep 2009 | - | $13.18M(-21.8%) |
| Jun 2009 | - | $16.85M(-5.3%) |
| Mar 2009 | - | $17.79M(-36.1%) |
| Dec 2008 | $27.82M(-73.5%) | $27.82M(-47.4%) |
| Sep 2008 | - | $52.90M(-3.3%) |
| Jun 2008 | - | $54.70M(-49.0%) |
| Mar 2008 | - | $107.18M(+2.2%) |
| Dec 2007 | $104.88M(+401.5%) | $104.88M(-20.1%) |
| Sep 2007 | - | $131.22M(-11.5%) |
| Jun 2007 | - | $148.28M(+118.2%) |
| Mar 2007 | - | $67.94M(-13.9%) |
| Dec 2006 | - | $78.95M(+283.0%) |
| Dec 2005 | $20.91M | $20.61M |
FAQ
- What is Jazz Pharmaceuticals plc annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc annual cash & cash equivalents year-on-year change?
- What is Jazz Pharmaceuticals plc quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc quarterly cash & cash equivalents year-on-year change?
What is Jazz Pharmaceuticals plc annual cash & cash equivalents?
The current annual cash & cash equivalents of JAZZ is $2.99B
What is the all time high annual cash & cash equivalents for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high annual cash & cash equivalents is $2.99B
What is Jazz Pharmaceuticals plc annual cash & cash equivalents year-on-year change?
Over the past year, JAZZ annual cash & cash equivalents has changed by +$1.37B (+84.03%)
What is Jazz Pharmaceuticals plc quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of JAZZ is $1.67B
What is the all time high quarterly cash & cash equivalents for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high quarterly cash & cash equivalents is $2.99B
What is Jazz Pharmaceuticals plc quarterly cash & cash equivalents year-on-year change?
Over the past year, JAZZ quarterly cash & cash equivalents has changed by -$310.92M (-15.70%)